Frenchick in Journal Sentinel on Pfizer stem-cell license with WARF

Attorney Grady Frenchick, a member of the UW Law School adjunct faculty with a specialization in intellectual property law, is quoted in the Milwaukee Journal Sentinel on the news that Pfizer Inc. has signed a license with the Wisconsin Alumni Research Foundation (WARF) to use human embryonic stem cells for the development of new drug therapies.

“No one should be surprised that even the big players are starting to sign, because it doesn’t make sense to sit on the sidelines any longer,” Frenchick told the Journal Sentinel. 

Click here for the full story, posted on the Journal Sentinel Web on May 5, 2009 and printed in the Business Section on May 6:


This article appears in the categories: In the Media

Submit an Article

lock